8VC is a venture capital firm specializing in technology and life sciences investments, aiming to partner with elite founders to build transformational technologies that create long-term economic and societal value.
8VC invests in early-stage companies across various sectors, including:
The firm seeks to back entrepreneurs aiming to address significant challenges through technological innovation.
In March 2025, 8VC announced the closing of its sixth flagship fund, 8VC Fund VI, with $998 million in new limited partner capital. This fund aims to support and partner with entrepreneurs at every stage of their journey and to build companies addressing critical areas such as healthcare, defense, logistics, finance, software, and biosciences.
Leadership
Investment Strategy
8VC combines its background as entrepreneurs, vantage point as investors, and a powerful talent network to launch companies addressing conceptual gaps in the market. Through its Build Program, 8VC identifies whitespaces and internal theses where there are opportunities to add value, often by tackling legacy technical systems in industries paralyzed by their scale.
Notable Investments
8VC has invested in several successful companies, including:
